Last updated on June 26th, 2024 at 04:09 pm
A groundbreaking study has shown that losing weight can protect against cancers associated with obesity. Obesity has long been linked to a higher risk of at least 13 types of cancer, primarily due to elevated levels of hormones such as estrogen and insulin. However, the latest research indicates that shedding excess pounds can improve a person’s odds of avoiding these cancers, including breast, kidney, ovary, liver, and pancreatic cancers.
“This study reinforces how crucial it is to treat obesity as a chronic disease,” said Dr. Kenda Alkwatli, a clinical fellow at Cleveland Clinic and one of the researchers involved in the study. “We are hopeful that these results can help us better understand how we can use weight loss to address co-morbidities, including cancer, in patients with obesity.”
Comprehensive Study on Obesity and Cancer
The research team evaluated the electronic health records of over 100,000 obese patients from the Cleveland Clinic, of whom more than 5,300 developed cancer. By tracking changes in BMI (Body Mass Index) over intervals of three, five, and ten years before a cancer diagnosis, researchers were able to draw significant conclusions about the impact of weight loss on cancer risk.
Also Read: Mysuru Residents Urge Ban on Newspaper-Wrapped Food Due to Cancer Risks
Key Findings
The study found that weight loss could reduce the risk of developing most obesity-related cancers within a five-year period. For instance, the risk of kidney cancer dropped within three years of weight loss, while the risk of endometrial cancer decreased within three to five years. Additionally, the risk of developing multiple myeloma fell within ten years of losing weight.
Beyond Obesity-Related Cancers
Interestingly, the study also discovered that losing weight appeared to protect individuals from a variety of other cancers not traditionally linked to obesity. These included melanoma and cancers of the skin, lungs, genitalia, eye, brain, and digestive organs. This broader protective effect underscores the potential health benefits of weight loss beyond the commonly known risks associated with obesity.
Future Research Directions
The researchers plan to investigate whether anti-obesity drugs like Wegovy and Zepbound can also reduce cancer risk. These medications have shown promise in helping patients achieve significant weight loss, and future studies could reveal their potential in cancer prevention.
Preliminary but Promising Results
The findings were presented at the American Diabetes Association‘s annual meeting in Orlando, Florida. While these results are promising, they are considered preliminary until they undergo peer review and are published in a scientific journal.
Also Read: Study Suggests Low Testosterone as Criterion for Bariatric Surgery in Obese Youths
Conclusion
This study highlights the critical importance of addressing obesity not just as a weight issue, but as a chronic disease with significant health implications. By focusing on weight loss, healthcare providers can potentially reduce the risk of numerous cancers, thereby improving overall health outcomes for obese patients. As research continues, new treatments and strategies may emerge to further support weight loss and cancer prevention.